2022 Clinical Guideline Toplines: Essential Summaries for Primary Care

Clinical practice guidelines and treatment decision pathways for multiple therapeutic areas were updated during 2022, including those for diagnosis and management of nonalcoholic fatty liver disease, heart failure management, obesity, and preexposure prophylaxis for HIV prevention.

For time-constrained primary care clinicians, Patient Care^® summarizes key additions and other changes to these evidence-based, "living" documents, in a Guideline Topline. These Toplines are at-a-glance slide shows, a convenient format to click through for the high-level kernels that may influence daily practice. (Please note that this collection is not comprehensive but reflects clinical areas frequently addressed in the primary care setting.)

Opioids for Pain Management: Guideline Topline for Primary Care

A guideline topline of the CDC's 2022 revised clinical recommendations for prescribing opioids for pain in adults.

Pharmacologic Interventions for Adults with Obesity: Guideline Topline for Primary Care

The American Gastroenterological Association released its first medical guideline recommending prescription medications for weight loss in adults with obesity. A review, here.

13 Medications to Avoid in Adults with Hypertension: A Guideline Topline for Primary Care

Reduce potential for promoting or worsening hypertension by stopping, reducing, or using alternatives to these 13 drugs and substances.

Causes of Secondary Hypertension: A Guideline Topline for Primary Care

Obstructive sleep apnea is a cause of secondary hypertension in up to 50% of cases; more common causes here, from the 2017 ACC/AHA hypertension guidelines.

White Coat & Masked Hypertension: A Primary Care Guideline Topline

White coat and masked hypertension can be elusive and dangerous. Click through a topline look at recommendations from the 2017 ACC/AHA hypertension guidelines.

Management of Nonalcoholic Fatty Liver Disease in Adults: Guidelines for Primary Care Clinicians

An overview of recommendations from the American Association of Clinical Endocrinology for the management of NAFLD in adults.

Diagnosis of Nonalcoholic Fatty Liver Disease in Adults: Guidelines for Primary Care

Get an overview of the recent AACE guidelines for diagnosing NAFLD in adults in primary care settings.

New AHA Statement on NAFLD and Cardiovascular Risk: A Guideline Topline

NAFLD is a key risk factor for ASCVD and widely underdiagnosed. This Guideline Topline summarizes new AHA warnings, guidance.

ACC, AHA, HFSA 2022 Heart Failure Management Guidelines: A Guideline Topline

The new HF guidelines prioritize primary prevention, revise disease stages to encourage early intervention, and now include SGLT2i as guideline-directed medical therapy.

PrEP for HIV Prevention: A Guideline Topline

The CDC update recommends that clinicians advise all sexually active patients about PrEP and includes a new section on prescribing injectable bimonthly cabotegravir.

Painful Diabetic Neuropathy Treatment: A Guideline Topline

The American Academy of Neurology recently issued a guideline on oral and topical treatments for painful diabetic neuropathy. Here, a concise summary for clinicians.